Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Environmental Management|September 27, 2023
Innovative spiral electrode configuration for enhancement of electrocoagulation-flotationEhsan Jafari, M Reza Malayeri, Heike Brückner, et al.
Thrombosis and Haemostasis|October 7, 2009
Genetic fusion to albumin improves the pharmacokinetic properties of factor IXHubert J Metzner, Thomas Weimer, Ulrich Kronthaler, et al.
Blood Cells, Molecules & Diseases|May 7, 2021
Identification of a modified coagulation factor X with enhanced activation properties as potential hemostatic agentMariana Ebert, Elmar Raquet, Sabine Schweisgut, et al.
Thrombosis and Haemostasis|April 9, 2008
Prolonged in-vivo half-life of factor VIIa by fusion to albuminThomas Weimer, Wilfried Wormsbächer, Ulrich Kronthaler, et al.
Circulation|February 13, 2003
Marburg I polymorphism of factor VII--activating protease: a prominent risk predictor of carotid stenosisJohann Willeit, Stefan Kiechl, Thomas Weimer, et al.
Thrombosis Research|July 9, 2013
Preclinical efficacy and safety of rVIII-SingleChain (CSL627), a novel recombinant single-chain factor VIIISabine B Zollner, Elmar Raquet, Jochen Müller-Cohrs, et al.
Thrombosis Research|May 13, 2014
Non-clinical pharmacokinetics and pharmacodynamics of rVIII-SingleChain, a novel recombinant single-chain factor VIIISabine Zollner, Elmar Raquet, Philipp Claar, et al.
British Journal of Haematology|March 29, 2016
FXIIa inhibitor rHA-Infestin-4: Safe thromboprotection in experimental venous, arterial and foreign surface-induced thrombosisFrauke May, Jennifer Krupka, Marion Fries, et al.
Pageof 2